Profil
Christopher W.
Morgan is currently Director at Alpha Cancer Technologies, Inc. Formerly, Mr. Morgan was Director at Spectra7 Microsystems, Inc. from 2021 to 2025 and Partner at Skadden, Arps, Slate, Meagher & Flom LLP.
Mr. Morgan earned an MBA from the University of Toronto.
Aktive Positionen von Christopher Morgan
| Unternehmen | Position | Beginn |
|---|---|---|
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher Morgan
| Unternehmen | Position | Ende |
|---|---|---|
| SPECTRA7 MICROSYSTEMS INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Corporate Officer/Principal | - |
Ausbildung von Christopher Morgan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Commercial Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spectra7 Microsystems, Inc.
Spectra7 Microsystems, Inc. SemiconductorsElectronic Technology Manufactures semiconductor products | Electronic Technology |
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Health Technology |
















